Clinical trials
Postoperative Pain trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 4 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 8 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 9 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tampere University Hospital | 10 |
| Kuopio University Hospital | 8 |
| Helsinki University Central Hospital | 7 |
| Turku University Hospital | 5 |
| Oulu University Hospital | 2 |
| Kati Järvelä | 1 |
| Mundipharma Oy | 1 |
| North Karelia Central Hospital | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| South Carelia Central Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Postoperative Pain | 38 |
| Pain | 3 |
| Constipation | 2 |
| Hernia, Inguinal | 2 |
| Postoperative Nausea and Vomiting | 2 |
| Aortic Valve Disease | 1 |
| Appendicitis | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Cholecystolithiasis | 1 |
| Chronic Pain | 1 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.